Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Edoxaban for Left Atrial Thrombosis Resolution
NCT03489395Phase 2Completed
- Start
- Jan 2018
- Primary completion
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of edoxaban in left atrial thrombosis. Started Jan 2018; status: completed.
02
Drugs
edoxaban
03
Conditions
left atrial thrombosis
Beyond the preview
Go deeper on NCT03489395.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03489395.